PET failure during inspection readiness: FDA/EMA investigation expectations


Published on 31/12/2025

Investigating PET Failure During Inspection Readiness: Compliance and CAPA Strategies

In the pharmaceutical industry, particularly in the manufacturing of ophthalmic and otic products, maintaining inspection readiness is critical to ensuring compliance with regulatory expectations. One frequent challenge encountered is the failure of package integrity tests (PET), which can lead to potential deviations and out-of-specification (OOS) results. This article will guide you through a structured approach to effectively investigate PET failures, implement corrective actions, and ensure a framework for continuous monitoring.

For deeper guidance and related home-care methods, check this Ophthalmic & Otic Products.

After reading this article, you will be equipped with practical strategies to investigate PET failures, identify root causes, and implement appropriate corrective and preventive actions (CAPA), aligned with FDA, EMA, and MHRA guidance.

Symptoms/Signals on the Floor or in the Lab

Identifying initial signals of PET failure is crucial to initiating timely investigations. Symptoms can manifest in various forms, and recognizing them early allows for effective decision-making. Common signals include:

  • Visual Inspection Failures:
Observations of defects such as bubbles, leaks, or tears in packaging.
  • Test Result Deviations: Results indicating packaging integrity is compromised, such as abnormal pressures during seal integrity tests.
  • Consumer Complaints: Reports of product malfunction or ineffectiveness due to compromised delivery systems.
  • Increased Scrappage Rates: Higher than average rejects during the quality control processes could signal underlying issues.
  • Non-Conformance Reports: Notifications of deviation concerning PET, often leading back to batch production records.
  • Likely Causes

    When investigating PET failures, it is essential to categorize potential causes according to the “5Ms”: Materials, Method, Machine, Man, Measurement, and Environment. These categories help structure the investigation.

    Category Potential Causes
    Materials Use of substandard or non-compliant materials; degradation of packaging material over time.
    Method Improper testing protocols or insufficient validation of procedures.
    Machine Equipment malfunctions, calibration issues, or maintenance neglect.
    Man Lack of operator training or human error during setup and testing.
    Measurement Inaccurate test results due to equipment or reagent issues.
    Environment Adverse conditions, such as high humidity or temperature fluctuations in storage or testing areas.

    Immediate Containment Actions

    Within the first hour of identifying a PET failure, immediate containment actions are critical to mitigating potential fallout. The following steps should be taken:

    1. Isolate Affected Batches: Segregate affected materials and products to prevent further use.
    2. Communicate Circuits: Alert relevant teams (Production, QA, QC) of the incident to initiate coordinated responses.
    3. Document Observation: Record the time of occurrence, initial observations, affected batches, and containment measures taken.
    4. Initiate Temporary Hold: Place affected products on hold until a thorough investigation is complete.
    5. Notify Regulatory Authorities: If necessary, engage regulatory authorities as stipulated by FDA, EMA, or MHRA guidelines on reporting deviations.

    Investigation Workflow

    The investigation workflow should encompass a logical series of data collection and analysis efforts. The data collection process should focus on:

    • Batch Production Records: Review historical data related to the affected batch.
    • Material Certificates: Evaluate the Certificates of Analysis (CoA) for all raw and packaging materials used.
    • Test Logs: Investigate previous test results to assess patterns or anomalies related to the failure.
    • Environment Monitoring Data: Examine environmental conditions during the production and testing phases.

    Interpreting the data involves looking for correlations and outliers that could indicate a root cause. Utilize visual aids, like control charts, to assess if variations fall within acceptable limits.

    Root Cause Tools

    Applying structured root cause analysis tools is essential in narrowing down the potential causes identified earlier. The following tools can be employed based on the complexity and context of the issue:

    • 5-Why Analysis: This method involves asking “why” five times to drill down through the layers of cause-and-effect. It is particularly useful for straightforward deviations.
    • Fishbone Diagram (Ishikawa): This tool allows teams to visually map potential causes across categories, facilitating group discussions and brainstorming.
    • Fault Tree Analysis: Best suited for complex systems, this approach breaks down failures into logical components, helping identify hidden failures in systems.

    Understanding when to apply each tool is key. For instance, use 5-Why when the problem appears to stem from a single source, while Fishbone is suitable for multifactorial investigations. Fault Tree Analysis is best for system-level failures.

    CAPA Strategy

    Once the root cause is established, developing an effective CAPA strategy is vital to rectify the issue and prevent recurrence. The CAPA process can be broken into three main components:

    • Correction: Implement immediate corrections to address the specific failure, such as re-evaluating affected products.
    • Corrective Action: Develop and implement a plan to eliminate the root cause identified in the investigation, such as retraining personnel or replacing faulty equipment.
    • Preventive Action: Implementing proactive measures or system changes to mitigate potential future risks, such as enhancing testing protocols or changing suppliers.

    Control Strategy & Monitoring

    Establishing a robust control strategy is crucial for sustaining compliance and ensuring PET is consistently within acceptance criteria. This involves:

    Related Reads

    • Statistical Process Control (SPC): Use statistical methods to continuously monitor manufacturing processes and detect deviations early.
    • Regular Sampling: Implement routine sampling of materials and products to ensure ongoing evaluation of package integrity.
    • Alarm Systems: Set up alerts for any deviations detected during routine quality checks to prompt immediate investigation and correction.
    • Verification Processes: Periodic reviews of processes and systems to validate the effectiveness of implemented CAPA actions.

    Validation / Re-qualification / Change Control Impact

    Should a PET failure occur, understanding its implications on validation, re-qualification, or change control processes is essential. If the failure impacts critical quality attributes or leads to changes in procedures, corresponding re-qualification must be undertaken.

    Furthermore, any alterations made to address the identified root cause will necessitate formal change control procedures, ensuring that regulations are upheld, and documented appropriately. When evaluating needs for re-validation, one must assess:

    • Scope of the change or failure
    • Potential impact on product quality and compliance
    • Regulatory and internal requirements for documentation and validation

    Inspection Readiness: What Evidence to Show

    During inspections, presenting clear evidence of a thorough investigation and effective CAPA measures is paramount. Documentation should include:

    • Records of Investigation: Detailed logs of the investigation process, findings, and discussions leading to the root cause.
    • TEST Logs and CAPA Documentation: Records detailing corrective actions taken and their implementation timelines.
    • Batch Manufacturing Records: Ensuring traceability of production batches linked to the deviation.
    • Training Records: Proof of training provided to relevant personnel post-investigation.
    • Environmental Monitoring Records: Evidence that conditions were maintained within prescribed tolerances.

    FAQs

    What is PET and why is it important?

    PET refers to package integrity testing, assessing the sealing quality of packaging to ensure product safety and effectiveness.

    How can I identify PET failures early?

    Frequent monitoring of visual inspections, test results, and consumer feedback can help catch failures early.

    What role does CAPA play in regulating failures?

    CAPA is essential for rectifying issues and preventing future occurrences while maintaining compliance with regulatory standards.

    Which root cause analysis tool is best for my investigation?

    Your choice of tool should depend on the complexity and nature of the failure, with 5-Why for simpler causes and Fault Tree for complex systems.

    What should my immediate response to a failure include?

    Immediate containment actions involve isolating affected products, alerting responsible personnel, and documenting the event.

    Is regulatory notification necessary after a PET failure?

    Notify regulatory authorities if deviations from compliance could affect product safety or efficacy.

    How often should control strategies be reviewed?

    Control strategies should be reviewed regularly or whenever there are significant changes to procedures or materials.

    What evidence is needed during inspections?

    Documentation of investigations, CAPA actions, training, batch records, and monitoring data is critical for inspection readiness.

    Pharma Tip:  CCIT failure during stability pull: batch disposition and patient risk assessment